Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer
Head & Neck Mar 01, 2018
Hamstra DA, et al. - This study was aimed to assess whether or not oral D-methionine (D-met) reduced mucositis during chemoradiotherapy. Mucositis was noted to decrease with D-met.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
